Filing Details

Accession Number:
0001062993-23-008102
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-30 17:39:49
Reporting Period:
2023-03-28
Accepted Time:
2023-03-30 17:39:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1042074 Cymabay Therapeutics Inc. CBAY Pharmaceutical Preparations (2834) 943103561
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1456750 D Dennis Kim C/O Cymabay Therapeutics, Inc.
7575 Gateway Blvd., Suite 110
Newark CA 94560
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-28 100 $4.37 20,100 No 4 M Direct
Common Stock Disposition 2023-03-28 100 $8.99 20,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2023-03-28 100 $0.00 100 $4.37
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
289,900 2031-05-16 No 4 M Direct
Footnotes
  1. The original option grant vested as to 1/4 of the underlying shares on May 17, 2022 and vests as to 1/48 of the underlying shares monthly thereafter.